MARKET

AMAM

Ambrx Biopharma Inc
AMAM
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-26.0652
1473.68
1.040
1,773,860,788.00
RPT-BUZZ-PREVIEW: Johnson & Johnson shares rise ahead of quarterly results
Shares in Johnson & Johnson rise 0.6% to $148.38 on Mon ahead of quarterly results. JNJ expected to report adj EPS of $2.64, down 1.54% from a year earlier. The company's quarterly results will be released before market open on Tues.
Reuters · 04/16 09:00
BUZZ-PREVIEW: Johnson & Johnson shares rise ahead of quarterly results
Shares in Johnson & Johnson rise 0.6% to $148.38 on Mon ahead of quarterly results. JNJ expected to report adj EPS of $2.64, down 1.54% from last quarter. The company's quarterly results will be released before market open on Tues.
Reuters · 04/15 16:53
Big Pharma patent cliffs seen fueling oncology M&A this year
Big Pharma patent cliffs seen fueling oncology M&A this year. Around $182B in revenue is at risk over the next four years due to patent expirations. Cantor Fitzgerald sees between five and 17 acquisition deals for oncologists in 2014. The global market for cancer drugs is expected to grow from $180B in 2022 to $323B in 2028.
Seeking Alpha · 03/10 17:08
*News On Ambrx Biopharma Inc. (AMAM) Now Under JNJ
Dow Jones · 03/07 22:08
Ambrx Biopharma’s Landmark Merger and Corporate Overhaul
TipRanks · 03/07 14:03
Ambrx Biopharma: Vote Results and Forward-Looking Statements Warning
TipRanks · 03/06 21:26
*Ambrx Hldrs Approve Acquisition by Johnson & Johnson
Dow Jones · 03/06 18:20
Press Release: Ambrx Shareholders Approve Acquisition by Johnson & Johnson
Ambrx Shareholders Approve Acquisition by Johnson & Johnson. More than 99% of the votes cast at the Special Meeting were voted in favor of adopting the merger agreement. Ambrx shareholders will receive $28.00 per share in cash in connection with the closing of the transaction. The company expects to complete the transaction on March 7, 2024.
Dow Jones · 03/06 18:20
More

Webull offers Ambrx Biopharma Inc stock information, including NASDAQ: AMAM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMAM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMAM stock methods without spending real money on the virtual paper trading platform.